RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice
J. Clin. Invest. Sergio Vaira, et al. 118:2088
doi:10.1172/JCI33392 [Go to this article.]

Figure 1
RelA is important for basal and stimulated OC formation in vivo. (A) TRAP-stained sections of vertebrae from Rela+/+ and Rela–/– RCs 4 months after bone marrow reconstitution. Scale bar: 100 μm. (B) Histomorphometric analysis was performed on TRAP-stained sections to determine the OC number (N.Oc./mm) and OC surface (Oc.S./BS.). *P < 0.05; n = 8/group. (C) Rela+/+ and Rela–/– RCs were injected with 100-μg RANKL or PBS daily for 5 days and sacrificed on the sixth day. TRAP-stained coronal sections of calvaria at the sagittal suture show a consistent increase in OCs along sutures and sinusoids only in Rela+/+ RANKL-treated animals. Scale bar: 200 μm. (D) Quantification of the N.Oc./mm and Oc.S./BS. (percentage of bone surface covered by OCs) along calvarial surfaces of mice in C confirms the significant difference in response of Rela+/+ and Rela–/– RCs to RANKL injection. In the PBS-injected animals, only rare OCs are detected in either genotype. P < 0.005; n = 5/group. (E) Serum levels of TRAP5b were determined 1 day prior to first RANKL injection (baseline) and at sacrifice on day 6 (RANKL). P = 0.01; n = 5/group.